JAMA Psychiatry Author Interviews

Guest Merete Nordentoft discusses the long-term effects of specialized early intervention services for first-episode schizophrenia spectrum disorder. The chapter explores the outcomes of the Opus trial, limitations of the study, and the importance of sustained positive results beyond the initial two years. It also emphasizes the effectiveness and implementation of early intervention programs for individuals with schizophrenia spectrum disorder.

Guest Cameron S. Carter discusses the use of technology-enhanced screening to reduce the duration of untreated psychosis. They explore the importance of early intervention, population-based screening methods, and the impact of technology on improving care.

Interview with Jari Tiihonen, MD, PhD, author of Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hosted by John Torous, MD, MBI. Related Content: Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

Weili Xu, researcher in the field of Mild Cognitive Impairment and Dementia, talks about the relationship between body mass index and brain health. They discuss previous studies on BMI and Alzheimer's disease, track BMI over time, and explore the association between brain pathology and BMI decline. They also highlight a study suggesting that BMI may decline years before the development of mild cognitive impairment, emphasizing the importance of regularly monitoring weight change among older adults.

Interview with Liane Schmidt, PhD, and Philippe Fossati, MD, PhD, authors of Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression. Hosted by John Torous, MD.

Interview with Angelica Ronald, PhD, author of Heritability of Heritability of Psychotic Experiences in Adolescents and Interaction With Environmental Risk . Hosted by John Torous, MD, MBI.

Interview with Michael P. Bogenschutz, MD, author of Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)

Interview with Cheng-Ta Li, MD, PhD, author of Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis. Hosted by John Torous, MD, MBI.

Interview with Peter Watkinson, MD, and Julia Hippisley-Cox, MD, authors of Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections. Hosted by John Torous, MD, MBI.